1999
DOI: 10.1289/ehp.99107377
|View full text |Cite
|
Sign up to set email alerts
|

Alteration in sexually dimorphic testosterone biotransformation profiles as a biomarker of chemically induced androgen disruption in mice.

Abstract: Assessment of the impact of environmental chemicals on androgen homeostasis in rodent models is confounded by high intraindividual and interindividual variability in circulating testosterone levels. Our goal was to evaluate changes in testosterone biotransformation processes as a measure of androgen homeostasis and as a biomarker of exposure to androgen-disrupting chemicals. Sexspecific differences in hepatic testosterone biotransformation enzyme activities were identified in CD-i mice. Gonadectomy followed by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 77 publications
(58 reference statements)
0
9
0
Order By: Relevance
“…For example, we observed significant induction of 15α-OH testosterone in CAR-null females, and a drop in 6β-OH testosterone production in CAR-null males compared to WT males (Fig 3). Therefore, we examined the 6α/15α-OH testosterone ratio, which is much greater in females than males, controlled by androgen status, and considered a biomarker of androgen disruption in mice [62]. The 6α/15α-OH testosterone ratio is 3.2-fold higher in WT females than WT males.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, we observed significant induction of 15α-OH testosterone in CAR-null females, and a drop in 6β-OH testosterone production in CAR-null males compared to WT males (Fig 3). Therefore, we examined the 6α/15α-OH testosterone ratio, which is much greater in females than males, controlled by androgen status, and considered a biomarker of androgen disruption in mice [62]. The 6α/15α-OH testosterone ratio is 3.2-fold higher in WT females than WT males.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, CAR may regulate sexual dimorphism in the liver as loss of CAR activity decreases the 6α/15α-OH testosterone ratio, a biomarker of masculinization of the liver [16, 62] that may also reflect an overall drop in CYP activity [61]. CAR expression is female predominant emphasizing the need to include both genders in drug trials and toxicant biotransformation studies [49, 71].…”
Section: Resultsmentioning
confidence: 99%
“…The female predominant 6α-hydroxylase activity also decreased in CAR-null females, but was not statistically significant. However, the 6α/15α-OH ratio, which is generally much greater in females, controlled by androgen status, and considered a biomarker of androgen disruption in mice (Wilson et al 1999), was decreased in CAR-null female mice. Because androgens are CAR inverse agonists, this suggests that CAR is involved in the androgen regulation of the gender predominant CYPs involved in 6α or 15α-OH activity.…”
Section: Resultsmentioning
confidence: 99%
“…The metabolism of testosterone and in particular the 6α/15α-hydroxlase ratio is decreased greater than 2.5-fold in female CAR-null mice compared to their wild-type counterparts. The 6α/15α-OH ratio, which is typically much greater in females, is in part controlled by androgens and considered a biomarker of androgen disruption or androgen status [194]. It is interesting that this ratio is effectively masculinized in female CAR-null mice [167].…”
Section: Sexual Dimorphismmentioning
confidence: 99%